This paper provides a comparative assessment of the draft “Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems” as proposed by the European Commission in October 2004. The Regulation...

The chemicals industry is a major contributor to the EU economy in terms of output, value-added, employment, and (net) exports. The sector supplies products to almost all downstream industry sectors and is an important engine for innovation for the wider economy. It plays a key role in...

This study deals with the post-acquisition integration of small biotechnology firms into the structure of large pharmaceutical companies. In this context, pharmaceutical companies face the paradox, that they need to integrate the biotechnology companies in some way in order to get access to the...

Die Arbeit befaßt sich mit den Veränderungen der Markt- und Firmenstruktur in der Pharma- und Biotechindustrie. Gegenstand der Untersuchung sind die Entstehung und Entwicklung der Biotechfirmen, Allianzen zwischen Biotech- und Pharmaunternehmen, Konzentrationstendenzen sowie die Integration...

Die pharmazeutische Industrie sowie das gesamte Gesundheitswesen stecken inmitten eines umfassenden Wandlungsprozesses. Solchen Wandlungen kann man am Besten mit Innovationen begegnen. Es müssen neue Ansätze umgesetzt werden, um die Produktivität weiter zu steigern. Weiterhin ist die stetige...

This study investigates how competencies lead to performance. We propose that salespersons in the Korean pharmaceutical industry require three central competency dimensions: motive and traits, self-concept, and knowledge and skills. Further, we argue that the level of salesperson competencies is...

Policy makers spend large amounts of public resources on the foundation of science parks and other forms of geographically clustered business activities, in order to stimulate regional innovation. Underlying the relation between clusters and innovation is the assumption that co-located firms...

This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...